These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 1337997

  • 21. Effect of dopa-loading on glutathione metabolising enzymes and tyrosinase in relation to 5-S-cysteinyl-dopa genesis in cultured B-16 melanoma cells.
    Chakraborty AK, Ichihashi M, Mishima Y.
    J Dermatol Sci; 1991 Sep; 2(5):329-35. PubMed ID: 1683790
    [Abstract] [Full Text] [Related]

  • 22. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
    Lai GM, Moscow JA, Alvarez MG, Fojo AT, Bates SE.
    Int J Cancer; 1991 Nov 11; 49(5):688-95. PubMed ID: 1682279
    [Abstract] [Full Text] [Related]

  • 23. Depletion of a discrete nuclear glutathione pool by oxidative stress, but not by buthionine sulfoximine. Correlation with enhanced alkylating agent cytotoxicity to human melanoma cells in vitro.
    Jevtović-Todorović V, Guenthner TM.
    Biochem Pharmacol; 1992 Oct 06; 44(7):1383-93. PubMed ID: 1417960
    [Abstract] [Full Text] [Related]

  • 24. Glutathione depletion increases tyrosinase activity in human melanoma cells.
    del Marmol V, Solano F, Sels A, Huez G, Libert A, Lejeune F, Ghanem G.
    J Invest Dermatol; 1993 Dec 06; 101(6):871-4. PubMed ID: 7902381
    [Abstract] [Full Text] [Related]

  • 25. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY, Teicher BA, Shea TC, Holden SA, Rosbe KW, al-Achi A, Henner WD.
    Cancer Res; 1989 Nov 15; 49(22):6185-92. PubMed ID: 2804968
    [Abstract] [Full Text] [Related]

  • 26. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
    Yang WZ, Begleiter A, Johnston JB, Israels LG, Mowat MR.
    Mol Pharmacol; 1992 Apr 15; 41(4):625-30. PubMed ID: 1569917
    [Abstract] [Full Text] [Related]

  • 27. Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
    Prezioso JA, Damodaran KM, Wang N, Bloomer WD.
    Biochem Pharmacol; 1993 Jan 26; 45(2):473-81. PubMed ID: 8435097
    [Abstract] [Full Text] [Related]

  • 28. Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.
    Prezioso JA, FitzGerald GB, Wick MM.
    J Invest Dermatol; 1992 Sep 26; 99(3):289-93. PubMed ID: 1512464
    [Abstract] [Full Text] [Related]

  • 29. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
    Armstrong DK, Gordon GB, Hilton J, Streeper RT, Colvin OM, Davidson NE.
    Cancer Res; 1992 Mar 15; 52(6):1416-21. PubMed ID: 1540950
    [Abstract] [Full Text] [Related]

  • 30. Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism.
    Medh RD, Gupta V, Awasthi YC.
    Biochem Pharmacol; 1991 Jul 05; 42(2):439-41. PubMed ID: 1859455
    [No Abstract] [Full Text] [Related]

  • 31. Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers.
    Ford JM, Hait WN, Matlin SA, Benz CC.
    Cancer Lett; 1991 Jan 05; 56(1):85-94. PubMed ID: 2004358
    [Abstract] [Full Text] [Related]

  • 32. Characterization of quinone reductase, glutathione and glutathione S-transferase in human myeloid cell lines: induction by 1,2-dithiole-3-thione and effects on hydroquinone-induced cytotoxicity.
    Li Y, Lafuente A, Trush MA.
    Life Sci; 1994 Jan 05; 54(13):901-16. PubMed ID: 7511200
    [Abstract] [Full Text] [Related]

  • 33. Modulation of glutathione level in cultured human melanoma cells.
    Karg E, Brötell H, Rosengren E, Rorsman H.
    Acta Derm Venereol; 1989 Jan 05; 69(2):137-41. PubMed ID: 2564231
    [Abstract] [Full Text] [Related]

  • 34. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM, Ozols RF.
    Cancer Res; 1984 Nov 05; 44(11):5427-31. PubMed ID: 6488194
    [Abstract] [Full Text] [Related]

  • 35. Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal.
    Spitz DR, Sullivan SJ, Malcolm RR, Roberts RJ.
    Free Radic Biol Med; 1991 Nov 05; 11(4):415-23. PubMed ID: 1797627
    [Abstract] [Full Text] [Related]

  • 36. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P, Loh SY, Kelland LR, Harrap KR.
    Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583
    [Abstract] [Full Text] [Related]

  • 37. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells.
    Chen G, Waxman DJ.
    Biochem Pharmacol; 1995 May 26; 49(11):1691-701. PubMed ID: 7786310
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
    Chao CC, Huang YT, Ma CM, Chou WY, Lin-Chao S.
    Mol Pharmacol; 1992 Jan 26; 41(1):69-75. PubMed ID: 1346333
    [Abstract] [Full Text] [Related]

  • 39. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
    O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF.
    J Clin Oncol; 1996 Jan 26; 14(1):249-56. PubMed ID: 8558205
    [Abstract] [Full Text] [Related]

  • 40. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.
    Russo A, DeGraff W, Friedman N, Mitchell JB.
    Cancer Res; 1986 Jun 26; 46(6):2845-8. PubMed ID: 2421885
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.